29 October 2025 in The Journal of Infectious Diseases
Background: The gastrointestinal (GI) tract is a major reservoir of HIV and home to the body's most diverse microbiome. However, the role of the gut bacteriome in modulating local HIV persistence remains uninvestigated. Methods: Leveraging rapid autopsy samples (n = 113) from 24 people with HIV in the Last Gift cohort, we performed 16S rRNA sequencing and quantified total HIV DNA and multiply spliced Tat/Rev RNA (droplet digital polymerase chain reaction) across 5 GI segments: duodenum, jejunum, ileum, colon, and rectum. Associations between the relative abundance of bacterial taxa and reservoir characteristics were analyzed via multivariable models. Results: HIV DNA levels were highest in the jejunum, intermediate in the duodenum and ileum, and lowest in the colon and rectum (P < .05 for all). HIV transcriptional activity was higher than expected relative to the reservoir size in the duodenum and ileum. Bacterial communities significantly differed in richness and composition across the segments (permutational multivariate analysis of variance, P = .002). Higher richness was associated with increased HIV transcriptional activity in the small bowel (ρ = 0.32, P = .015) and decreased activity in the large bowel (ρ = −0.41, P = .013). Segment-specific associations between taxa and HIV reservoir were observed: among these, short-chain fatty acid producers, mucin degraders, and bile acid metabolizers were consistently associated with reduced reservoir size and activity in the large bowel but with enhanced transcription in proximal segments. Sensitivity analyses by antibiotic exposure, cancer, and viral load confirmed robustness of findings. Conclusions: The gut bacteriome modulates HIV reservoir size and activity, and these effects vary along the GI tract. This regional specificity must be considered when designing bacteriome-based strategies to reduce HIV persistence and improve cure efforts.
11 July 2025 in Open Forum Infectious Diseases
Background: As the US human immunodeficiency virus (HIV) epidemic is disproportionately affecting underserved communities, it is critically important to investigate how social determinants of health affect diagnosis, treatment, and prevention of HIV infection and access to care. This article presents an investigation of the HIV epidemic in Clark County, Nevada, to identify local predictors of progression along the HIV care continuum. Methods: Deidentified HIV surveillance data from 2011 to 2022 were analyzed. We investigated associations between stages of care and individual-level demographics and zip code–level characteristics using (1) generalized linear mixed-effects models for univariate analysis, (2) penalized generalized linear mixed-effects models to simultaneously conduct variable selection and estimation for multivariate analysis, and (3) geospatial analysis. Results: Individual-level factors (diagnosis year, age at diagnosis, being Hispanic, being a man who has sex with men, sex at birth, and individual-level membership in a genetic cluster) and zip code–level factors (genetic clustering and social determinants of health, including level of poverty, proportion Hispanic, proportion with high school education, proportion white, and employment status) were associated with progression through the care continuum. A key result from our multivariate analysis is higher-poverty areas are associated with lower rates of persons with HIV in care (estimate [SE], −0.42 [0.17]; P = .02) and viral suppression (−0.48 [0.15]; P = .001). Conclusions: Our findings highlight the need for linking and engaging individuals in higher-poverty neighborhoods to medical providers. Furthermore, our results support the need for additional treatment adherence services in those same neighborhoods to increase viral suppression rates.
7 October 2026 in The Journal of Infectious Diseases
Background: Cytomegalovirus (CMV) is highly prevalent and associated with comorbidities in people with HIV-1 (PWH). Cytomegalovirus contributes to systemic inflammation, but comprehensive analyses of the plasma proteome in PWH with or without CMV are lacking. Methods: Plasma proteomes from 59 age- and CD4 count-matched PWH on suppressive antiretroviral therapy with (CMV+) or without (CMV−) CMV were characterized by inflammation- and cardiometabolic-focused proteomics proximity extension assays. Normalized protein expression values were analyzed using linear mixed-effects models, partial least squares-discriminant analysis, and gene set enrichment analysis. T-cell phenotypes were assessed by flow cytometry. Results: In covariate-unadjusted linear mixed-effects models, 118/350 (33.7%) inflammatory and 27/363 (7.4%) cardiometabolic proteins were differentially expressed (false discovery rate-adjusted P < .05). Proteins most significantly upregulated in CMV+ participants were associated with immune inhibition (eg, FcRL6, LY9, and HLA-DRA), cytotoxic differentiation (eg, KLRD1, CD70, and SLAMF7), and interferon-associated chemotaxis (eg, CXCL9 and CXCL10). Several of the most significantly downregulated proteins in CMV+ PWH were associated with apoptosis (eg, CASP2, TRIM21, and TRAF2). Surface FcRL6 expression was significantly elevated on CD57+CD28− CD8 T cells of CMV+ PWH. Conclusions: These data identify a CMV-associated plasma proteomic signature in treated HIV, characterized by immunoinhibitory/cytotoxic programs, supporting targeting CMV to reduce immune dysregulation and related comorbidities in PWH.
24 December 2025 in Open Forum Infectious Diseases
Background: Antiretroviral therapy (ART) suppresses HIV replication and partially restores immune function, but immunologic abnormalities often persist. Methods: We performed longitudinal multiparametric flow cytometry on peripheral blood mononuclear cells from 79 people with HIV-1 (51 women, 28 men) who were virologically suppressed and followed over a median 6 years of ART. We assessed T-cell counts and expression of activation (CD38⁺HLA-DR⁺), cycling (Ki67⁺), exhaustion (TIGIT⁺PD-1⁺), cytotoxicity (CD107a⁺), and regulatory (FoxP3⁺CD25⁺) markers across memory subsets, and we examined associations with sex and HIV reservoir size and activity. Results: CD4⁺ T-cell counts increased and CD8⁺ T-cell counts declined over time, improving CD4/CD8 ratios. Immune activation and cycling markers decreased in both T-cell compartments. TIGIT/PD-1 expression declined significantly in CD4⁺ memory subsets but not in CD8⁺ T cells, while CD107a expression remained elevated in effector memory CD8⁺ and CD4⁺ T cells. Regulatory CD4⁺ T cells declined over time, and no significant associations were observed between T-cell phenotypes and HIV reservoir measures or between sexes. Conclusions: Long-term ART promotes partial immune normalization, including reduced activation and reversal of CD4⁺ T-cell exhaustion. However, persistent expression of CD8⁺ T-cell surrogate markers of exhaustion and stable cytotoxic profiles suggest ongoing antigenic stimulation, potentially driven by HIV or chronic coinfections.